This company is using AI to develop drugs. Schizophrenia is its first target

PsychoGenics developed a drug-discovery platform that’s powered by AI. Its first drug candidate could be a game changer for treating schizophrenia.

Let’s play a game. I’ll think of a word—any word, any length, any language. Then, you’ll try to guess it. You’ll get hints if you’re on the right track, but each guess will cost you millions and take you years. Are you in?

Read Full Story